InsiderInsights.com Daily Round Up: 7/8/14

|
 |  Includes: BKFG, COO, DY, FSL, GBIM, GOOG, LIOX, LTS, MDSO, MON, NMBL, OPK, PAYX, REGN, YELP, Z
by: InsiderInsights

Summary

Tables of the top insider purchases and sales filed with the SEC on Tuesday, July 8, 2014, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are further given for selected companies.

I cannot repeat enough that dollar value is only one metric to assess the significance of an insider transaction. InsiderInsights calculates Insider Filer Statistics in real time, and formulates Insider Company Ratings based on numerous behavioral factors, so our clients can separate real investment intelligence from time-wasting noise.

On Today's Tables:

Insider trades were rated Significant at:

  • YELP (NYSE:YELP);
  • Opko Health (NASDAQ:OPK), and;
  • Ladenburg Thalmann Financial (NYSEMKT:LTS).

Insider trades were rated Nearly Significant at:

  • Regeneron Pharmaceuticals (NASDAQ:REGN), and;
  • Nimble Storage (NYSE:NMBL).

Insider trades were considered Insignificant at:

  • Monsanto Company (NYSE:MON);
  • Google (NASDAQ:GOOG);
  • Freescale Semiconductor (NYSE:FSL);
  • Paychex (NASDAQ:PAYX);
  • Medidata Solutions (NASDAQ:MDSO);
  • Lionbridge Technologies (NASDAQ:LIOX);
  • The Cooper Companies (NYSE:COO);
  • TRULIA (TRLA), and;
  • BKF Capital (OTCPK:BKFG).

There is a Conflicted Insider Signal at:

  • Dycom Industries (NYSE:DY).

The Insider Purchase at GlobeImmune (NASDAQ:GBIM) was associated with its recent IPO. This was nice to see, but it's difficult to argue significance for transactions by insiders without track records of unseasoned shares.

For more on how to profit from our Daily Round Up tables and analyze insider data, see references below.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Sanofi BO Regeneron Pharm REGN AB $111,422,744
2 Celgene Intl BO Globeimmune GBIM JB* $2,000,000
3 Healthcare Vent BO Globeimmune GBIM JB* $1,900,000
4 Coe Charles B DIR Dycom Industries DY B $465,762
5 Frost Phillip Md DIR,BO Ladenburg Thalmann LTS B $349,530
6 Frost Phillip Md CEO,CB,BO Opko Health OPK B $237,436
7 Gilinski Saul DIR Ladenburg Thalmann LTS B $34,850
8 Bronson Steven N CEO,DIR,BO Bkf Capital BKFG B $33,930
9 Green George D CEO,DIR,BO Union Dental UDHI JB* $14,850
10 Cali Brian J DIR Fidelity D & D Bancorp FDBC JB* $10,000
Click to enlarge

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes:
B=Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Parfet William U DIR Monsanto MON S $3,011,079
2 Pichette Patrick VP,CFO Google GOOG AS $1,699,978
3 Lowe Gregg A CEO,DIR Freescale Semi FSL S $1,575,224
4 Mhatre Ravi BO Nimble Storage NMBL S $1,220,774
5 Mucci Martin CEO,PR,DIR Paychex PAYX JS* $1,093,139
6 Stoppelman Jeremy CEO,DIR,BO YELP YELP AS $1,058,805
7 Sherif Tarek CB,CEO Medidata MDSO AS $864,016
8 Glenhill Advisors BO Lionbridge Tech LIOX S $762,012
9 Bender A Thomas DIR Cooper Companies COO S $724,048
10 Flint Peter CEO,DIR Trulia TRLA AS $473,677
Click to enlarge

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes:

S=Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Did you miss our Previous Daily Round Up?

An important note from Jonathan Moreland, founder of InsiderInsights.com:

In a victory for common sense, it's been proven profitable -- by both academic studies and (more importantly) the experience of your fellow professional investors -- to monitor the trading behavior of company executives, directors, and large shareholders in the stocks of firms of which they're registered as "insiders".

Please note, however, that the lists above are strictly factual; they are not buy and sell recommendations.

At InsiderInsights.com, our clients find new investment ideas every day using more intricate insider screens to determine where they should focus their subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be profitable indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

So use these daily articles as the initial research tools they are meant to be, and click the links in the tables to analyze a company's or insider's full insider history. Also feel free to email us with any questions on our proprietary insider data, filer statistics, and company ratings.

I should also relay that you could have seen the trades on today's Daily Round Up tables within hours of being filed, by signing up for our Free Intra-Day Top Trades Alerts.

Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. The author wrote this article themselves, and it expresses their own opinions. The author is not receiving compensation for it (other than from Seeking Alpha). The author has no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.